0001213900-23-000317.txt : 20230103
0001213900-23-000317.hdr.sgml : 20230103
20230103150209
ACCESSION NUMBER: 0001213900-23-000317
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230101
FILED AS OF DATE: 20230103
DATE AS OF CHANGE: 20230103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mark Elad
CENTRAL INDEX KEY: 0001960205
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37353
FILM NUMBER: 23501732
MAIL ADDRESS:
STREET 1: 27 HAILANOT
CITY: HERZLIYA
STATE: L3
ZIP: 4631214
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BiondVax Pharmaceuticals Ltd.
CENTRAL INDEX KEY: 0001611747
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: JERUSALEM BIOPARK, 2ND FLOOR
STREET 2: HADASSAH EIN KEREM CAMPUS
CITY: JERUSALEM
STATE: L3
ZIP: 00000
BUSINESS PHONE: 972-8-9302529
MAIL ADDRESS:
STREET 1: JERUSALEM BIOPARK, 2ND FLOOR
STREET 2: HADASSAH EIN KEREM CAMPUS
CITY: JERUSALEM
STATE: L3
ZIP: 00000
3
1
ownership.xml
X0206
3
2023-01-01
0
0001611747
BiondVax Pharmaceuticals Ltd.
BVXV
0001960205
Mark Elad
JERUSALEM BIOPARK, 2ND FLOOR
HADASSAH EIN KEREM CAMPUS
JERUSALEM
L3
9112001
ISRAEL
0
1
0
0
Chief Operating Officer
Restricted Share Units
2024-10-18
2031-10-16
Ordinary Shares
360000
D
Restricted Share Units
2025-03-23
2032-03-23
Ordinary Shares
1412000
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents four hundred Ordinary Shares.
Each restricted share unit represents a contingent right to receive one ordinary share.
/s/ Elad Mark
2023-01-03